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Abstract 
Background: Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale 
retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute 
variceal bleeding and to validate the current prognostic models. 
Methods: Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to 
March 2020. The independent prognostic factors for in-hospital death were identified by logistic 
regression analyses. Area under curves (AUCs) was compared among Child-Pugh, cirrhosis 
acute gastrointestinal bleeding (CAGIB) score, model for end-stage liver disease (MELD) and 
neutrophil-lymphocyte ratio (NLR) scores. 
Results: Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively 
evaluated. The majority of the patients were males (59.1%) and the mean age of all patients 
were 53.7±1.3 years (range 14-89). Hepatitis B virus (HBV) was the most common underlying 
cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate 
logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum 
creatinine and ALT were independently associated with in hospital death. And the odds ratios 
(ORs) for in hospital death were 1.066 (95%CI 1.017-1.118, P=0.008), 7.19 (95%CI 
2.077-24.893, P=0.001), 1.123 (95%CI 1.051-1.201, P=0.001), 1.014 (95%CI 1.005-1.023, 
P=0.003), 1.012 (95%CI 1.004-1.021, P=0.006), 1.005 (95%CI 1.000-1.009, P=0.036), 
respectively. In the whole cohort with HCC patients, the AUCs of Child-Pugh, CAGIB, MELD 
and NLR scores were 0.842 (95%CI 0.801-0.878), 0.840 (95%CI 0.799-0.876), 0.798 (95%CI 
0.754-0.838) and 0.688 (95%CI 0.639-0.735), respectively. The differences were statistically 
significant between Child-Pugh and NLR scores (P=0.0118), and between CAGIB and NLR 
scores (P=0.0354). 
Conclusion: Child-Pugh and CAGIB scores showed better predictive performance for prognosis 
of patients with cirrhosis and acute variceal bleeding than NLR scores. 
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Acute variceal bleeding is a frequent medical emergency with the 6-week mortality of 15-20% in 
patients with liver cirrhosis.1,2 Hepatocellular carcinoma (HCC) is one of the most common 
tumors worldwide with approximately 850,000 new cases each year3. The HCC patients with 
cirrhosis may suffer from both the tumor burden and variceal bleeding associated with liver 
cirrhosis. Combined treatment with prophylactic antibiotics, vasoactive drugs, endoscopic 
techniques and interventional treatments are the recommended therapy methods for patients 
with acute variceal bleeding. However, treatment failure remains as high as 20% 4.  
The consensus suggested the importance of early use of risk stratification scores in patients 
with acute upper gastrointestinal bleeding, which could help reduce the costs and resources 
without influencing the outcomes of patients 5. Conventional scoring systems with acute upper 
gastrointestinal bleeding included Glasgow-Blatchford score (GBS), Rockall score and AIMS65 
score 6-8. However, these systems were not designed for patients with cirrhosis. As we know, 
variceal bleeding are the most frequent reasons of acute upper gastrointestinal bleeding in 
patients with liver cirrhosis. Recent studies have showed that these scoring systems were 
successful for predict mortality risk in patients with nonvariceal upper gastrointestinal 
bleedings9,10. Oakland et al. developed a new scoring system based on the data from Canada, 
United Kingdom and Australia (CANUKA), which was used to identify low-risk patients with 
30-day rebleeding or death 11. Tammaro et al. developed T-score to predict high-risk endoscopic 
stigmata and the need for early intervention 12. Robertson et al. validated the AIMS65 score and 
found that AMIS65 score was equivalent to other liver disease severity risk stratification scores 
in predicting short term mortality13. However, these scoring systems were designed for acute 
upper gastrointestinal bleeding rather than for liver cirrhosis patients with acute variceal 
bleeding. Although multiple scoring systems have been proposed about liver diseases or acute 
upper gastrointestinal bleeding, very limited data are available for the prognostic value of 
current scoring systems in patients with acute variceal bleeding. 
Child-Pugh, model for end-stage liver disease (MELD) and neutrophil-lymphocyte ratio (NLR) 
scores have been widely used in clinical practice considering they were used for prognostic 
assessment in patients with liver cirrhosis. Child-Pugh score was proposed to predict the risk of 
surgery for patients with variceal bleeding. MELD score was designed to predict the prognosis 
of patients who received transjugular intrahepatic portosystemic shunts (TIPS) therapy. 
Currently it has been widely used to rank the priority of liver transplantation candidates. NLR is 
a scoring system through evaluating the degree of inflammation reaction and has been 
considered as a marker for the severity of liver fibrosis and cirrhosis. Lately cirrhosis acute 
gastrointestinal bleeding (CAGIB) was proposed by Bai, et al. They use a large scale of patients 
with cirrhosis and acute gastrointestinal bleeding to propose and validate the performance of 
CAGIB score. And their results showed that CAGIB score performed better than Child-Pugh, 
MELD and NLR 14. Although several previous studies have compared the discriminative abilities 
of the staging systems, it still remains controversial which could reflect the prognosis more 
accurately. 
Therefore, we conducted this large cohort retrospective study to evaluate the prognostic factors 
for the liver cirrhotic patients with acute variceal bleeding and further to compare the 
discriminate ability of these current stage systems. 
 
Methods 
We screened all consecutive patients with acute gastrointestinal bleeding who were admitted to 
our hospital between January 2019 and March 2020. The inclusion criteria were acute variceal 
bleeding because of liver cirrhosis. The time frame for the acute bleeding episode should be 
120h (5 days) according to the Baveno V criteria 15. The exclusion criteria were ulcer diseases, 
acute gastric mucosa hemorrhage, Mallory-Weiss syndrome, tumor diseases related bleeding, 
inflammatory bowel diseases, obscure gastrointestinal bleeding and other reasons-caused 
bleeding. All consecutive patients who met these criteria were included. Because of the nature 
of this study the informed written consent was waived. The following data were collected: age, 
gender, etiology, α-fetoprotein (AFP), history of GIB, hepatic encephalopathy (HE), ascites, and 
the laboratory tests at admission including white blood cell (WBC), platelet (PLT), hemoglobin 
(Hb), red blood cell (RBC), total bilirubin (TBIL), albumin (ALB), alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) alkaline phosphatase (ALP), gamma-glutamyl 
transpeptidase (γ-GGT), prothrombin time (PT), international normalized ratio (INR), serum 
creatinine (Scr) and in-hospital death. Child–Pugh, CAGIB, MELD and NLR scores were 
calculated for every patient, respectively.16-18 
MELD=0.957×loge (creatinine mg/dL) + 0.378 × loge (bilirubin mg/dL) +1.120 × loge (INR) + 
0.643 × (cause of cirrhosis). For cause of cirrhosis, use 0 for alcohol-related liver disease or for 
cholestatic liver disease; 1 for all other causes. 
CAGIB = Diabetes (yes = 1, no = 0) ×1.040 + HCC (yes = 1, no = 0) ×0.974 + TBIL(μmol/L) 
×0.005 - ALB (g/L) × 0.091 + ALT(U/L) ×0.001 + Scr (μmol/L) ×0.012 - 3.964 
The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte 
count. NLR ≥ 5 was considered raised19. 
The Child-Pugh scores were consisted of encephalopathy, ascites, bilirubin, albumin, 
prothrombin time and INR. The patients whose score 5 or 6 were good operative risks (grade A), 
7, 8 or 9 moderate (grade B), and patients with 10-15 poor operative risks (grade C) 20. 
 
Statistical analysis 
Continuous variables were summarized as the means and standard deviation. Categorical 
variables were expressed as frequencies and percentages. Logistic regression analyses were 
used to assess the prognostic values of the variables associated with in hospital death. Odds 
ratios (ORs) with 95% confidence intervals (CIs) were calculated. Then, receiver operating 
characteristic curve (ROC) analysis was performed to evaluate the predictive performance of 
Child-Pugh score, CAGIB score, MELD score and NLR score. The area under curve (AUC) was 
calculated. The predictive performance of each scoring system was compared. All statistical 
analyses were performed using SPSS software version 17.0 (IBM Corp, Armonk, NY, USA) and 
MedCalc software version 19.0.4 (MedCalc Software, Mariakerke, Belgium). P<0.05 was 




Overall, we followed 711 consecutive patients with acute upper gastrointestinal bleeding who 
admitted to our hospital from Jan 2019-March 2020. Of these patients, 379 with liver cirrhosis 
and acute variceal bleeding were consecutively evaluated (Figure 1). Detailed baseline clinical 
characteristics of these enrolled patients were provided in Table 1. The majority of the patients 
were males (59.1%). The mean age of all patients were 53.7±1.3 years (range 14-89). 
Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 
(19%) patients had hepatocellular carcinoma. Nine patients had underwent liver transplantation, 
96 (25.3%) underwent TIPS treatment. 157 (41.4%) patients received endoscopic variceal 
ligation treatment and 144 (38%) had gastric variceal obturation treatment.  
 
Univariate and Multivariate analyses 
Univariate logistic regression analyses demonstrated that age, hepatitis infection, HCC, WBC, 
RBC, albumin, total serum bilirubin, serum creatinine, ALT, AST, alkaline phosphatase, 
Child-Pugh score, MELD score, NLR score, CAGIB score were significantly associated with in 
hospital death. Multivariate logistic regression analyses showed that age, HCC, WBC, total 
serum bilirubin, serum creatinine and ALT were independently associated with in hospital death. 
And the odds ratios (ORs) for in hospital death were 1.066 (95%CI 1.017-1.118, P=0.008), 7.19 
(95%CI 2.077-24.893, P=0.001), 1.123 (95%CI 1.051-1.201, P=0.001), 1.014 (95%CI 
1.005-1.023, P=0.003), 1.012 (95%CI 1.004-1.021, P=0.006), 1.005 (95%CI 1.000-1.009, 
P=0.036), respectively (Table 2). Child-Pugh score, MELD score, and NLR score are compex 
variables composed of many clinically significant variables, and therefore they were not 
included in the multivariate analysis. 
In the whole cohort including HCC patients, the AUCs of Child-Pugh, CAGIB, MELD, NLR 
scores were 0.842 (95%CI 0.801-0.878), 0.840 (95%CI 0.799-0.876), 0.798 (95%CI 
0.754-0.838) and 0.688 (95%CI 0.639-0.735), respectively (Figure 2). The differences were 
statistically significant between Child-Pugh and NLR scores (P=0.0118), and between CAGIB 
and NLR scores (P=0.0354). 
In the cohort without HCC patients, the AUCs of Child-Pugh, CAGIB, MELD, NLR scores were 
0.864 (95%CI 0.820-0.900), 0.780 (95%CI 0.729-0.826), 0.800 (95%CI 0.750-0.844) and 0.747 
(95%CI 0.694-0.795), respectively (Figure 3). The differences between CAGIB, Child-Pugh, 
MELD and NLR scores were not statistically significant.  
 
Discussion 
Acute variceal bleeding is a lethal complication of liver cirrhosis. Although some scoring models 
were used to predict the prognosis and mortality in liver cirrhosis and acute upper 
gastrointestinal bleeding, the prognostic scoring system for the mortality of patients with acute 
variceal bleeding was relatively rarely. The present work evaluated the prognosis of patients 
with liver cirrhosis and acute variceal bleeding and further validated the prognostic ability of 
current models. The strengths of this study were as follows: (1) the data was obtained from the 
large sample size and the patients with cirrhotic liver and acute variceal bleeding were 
consecutively enrolled; (2) we evaluated the prognosis of HCC patients with acute variceal 
bleeding; (3) most of the cases in our cohort were caused by HBV infection which differed from 
the patients in western countries; (4) this is the first study as an external validation of CAGIB 
score in patients with cirrhosis and acute variceal bleeding.  
Currently, Child-Pugh, MELD and NLR scores are the most widely known staging scores. Firstly, 
Child-Pugh is one of the oldest and useful tools utilized in clinical practice to estimate the 
prognosis of liver cirrhosis. Although Child-Pugh score has some limitations considering that it 
includes some subjective factors, such as ascites and hepatic encephalopathy which would be 
affected by therapy, it is still the most widely used prognostic scoring system for liver cirrhosis 
patients worldwide 21. In our study, Child-Pugh was shown to be a reliable scoring system with 
the highest AUCs, which was higher than MELD, CAGIB and NLR. 
Secondly, considering all the patients with score more than 10 were classified as Class C in 
Child-Pugh system, it was suggested that Child-Pugh classification could not discriminate the 
patients with serious damaged liver function 17. Under this background, MELD was created to 
predict the survival of patients TIPS treatment and now has been used to evaluate the priority of 
liver transplantation 17. A previous study by Salerno F, et al. demonstrated that MELD score 
performed better than Child-Pugh model in predicting short-term (3 month) outcome 22. Then 
the study by Schepke M, et al. suggested that there was only slight difference in the predictive 
accuracy of 1 year survival between these two models 23. However, some studies have shown 
that MELD correlated well with Child-Pugh score 24. Moreover, the study by Serste et al. 
demonstrated that MELD score failed to predict the mortality in patients with refractory ascites 25. 
The limitation of MELD is that it originated from advanced liver disease. And the calculation of 
MELD score is very more complex compared with others. Thus it still remains controversial 
about the advantage of MELD in clinical practice.  
Thirdly, NLR is a scoring system that reflects the degree of inflammatory reaction with 
integrating two immune pathways. On one hand, neutrophils indicate the continuous 
inflammation; On the other hand, lymphocytes indicate the regulatory pathway 19. NLR has 
been considered as a prognostic marker for patients with various tumors including HCC, gastric 
cancer and lung cancer, etc. 26,27. The advantage of NLR is that the value of neutrophils and 
lymphocytes could be easily obtained in clinical practice. And as we know, the inflammatory 
reaction process plays an important role in the progression of liver fibrosis and cirrhosis. Thus, it 
was suggested that NLR could be used as a marker for the severity of liver fibrosis and cirrhosis. 
The systematic review by Peng, et al. pointed that NLR was particularly associated with the 
degree of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) 28. This is 
associated with the fact that inflammatory reaction is evolved in the progression of NAFLD. 
However, NLR failed to reflect other factors that may reflect the severity of liver damages. 
CAGIB was recently proposed to predict the prognosis of patients with cirrhosis and acute 
gastrointestinal bleeding. It includes TBIL, ALB, Scr, ALT, diabetes and HCC as variables 
predicting prognosis. In our study we identified age, HCC, WBC, TBIL, Scr and ALT as 
prognostic factors, which was similar with CAGIB score. In real world practice, the rapid 
increase in Scr level indicated decreased kidney function. The importance of Scr level as a 
critical prognostic factor for patients with liver disease has been proved in previous studies29,30. 
It was suggested that patients with renal failure and liver cirrhosis would had worse prognosis 
compared to patients with similar severity of liver disease 31. In addition, in the training cohort 
and internal validation cohort in CAGIB score there were around 14%-18% HCC patients, which 
was similar with the percentage of HCC patients in our cohort 14. And HCC with over a 7-fold 
increased risk of in hospital death played a crucial role in the prognosis. 
All in all, a previous systematic review by Peng, et al. compared the Child-Pugh and MELD 
scores in the evaluation of prognosis in patients with liver cirrhosis and found that both of them 
had similar prognostic value. However, these two scoring systems performed differently 
depending on specific conditions. They pointed that studies should illustrate clearly the 
candidates who should use Child-Pugh or MELD32. Our study showed that in the whole cohort 
including HCC, the AUCs of Child-Pugh and CAGIB were higher than that of MELD and NLR 
scores. And the differences reached statistically significant between Child-Pugh and NLR 
scores, and between CAGIB and NLR scores. These results implied that Child-Pugh and 
CAGIB had better performance than NLR in the evaluation of prognosis for patients with 
cirrhosis and acute variceal bleeding. We considered that the possible reason was the etiology 
of our patient mainly consisted of hepatitis infection rather than NAFLD. And 19% patients had 
tumor burden which was an important prognostic factor. NLR, as an index including 
inflammation markers, could not reflect accurately both the degree of liver function damage and 
the effect of tumor burden.  
There are a few limitations to our study that need to be acknowledged. Firstly, this is a 
single-center study; the lack of data from multicenter may cause potential bias. Secondly, this is 
a retrospective study and patients received different treatments to stop bleeding. 25.3% patients 
received TIPS treatment, 41.4% patients received endoscopic variceal ligation treatments and 
38% had gastric variceal obturation treatments. The various treatment methods may possibly 
affect the prognostic. However, there was no treatment related death in this study.  
 
Conclusions 
In conclusion, our study demonstrated that in the current models, Child-Pugh, CAGIB and 
MELD had good prognostic ability in predicting the prognosis of liver cirrhotic patients with acute 
variceal bleeding. Child-Pugh and CAGIB performed better than NLR in the cohort including 
HCC patients.  
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Figure 2. Comparisons of predictive performance of CAGIB score with Child–Pugh, MELD and 
NLR score in liver cirrhotic patients including HCC. Blue line refers to the Child–Pugh score, 
green line refers to the CAGIB score, orange line refers to the MELD score, and black dotted 

















Figure 3. Comparisons of predictive performance of CAGIB score with Child–Pugh, MELD and 
NLR score in liver cirrhotic patients without HCC. Green line refers to the Child–Pugh score, 
blue line refers to the CAGIB score, orange line refers to the MELD score, and black dotted line 














Table 1. Demographic, clinical and biochemical characteristics in patients with acute gastrointestinal 
bleeding（n=379). 
  N  
Age (y) (mean± SD) 53.7±1.3（range 14-89） 
Sex (male) 224（59.1%） 
Cause of cirrhosis  
   Hepatic B virus 205（54.1%） 
  Hepatic C virus 30（7.9%） 
  Both hepatic B and C virus 2（0.5%） 
  Autoimmune liver disease 42（11.1%） 
  Alchohoic 9（2.4%） 
  Other 91（24%） 
History of GIB 86（22.7%） 
Ascites 229（60.4%） 
Hepatic encephalopathy 9（2.4%） 
Hepatocellular carcinoma 72（19%） 
Baseline laboratory values, mean±SD (range) 
   White blood cell (×109/L) 5.3±5.3 (0.93-64.86) 
  Platelet (×109/L) 78.2±5.8 (1-511) 
  Red blood cell(×109/L) 2.8±0.7 (1.2-5.4) 
  Hemoglobin (g/L) 82±2.4 (23-105) 
  Albumin (g/dL) 31.2±5.9 (14.5-55) 
  Total Serum bilirubin (μmol/L) 36.7±5.3 (2.3-662.4) 
  Serum creatinine (μmol/L) 63.3±4.3 (11-513) 
  International normalized ratio 2.2±1.1 (0.97-1.74) 
  Alanine aminotransferase (U/L) 39.1±6.5 (2.4-734) 
  Aspartate aminotransferase (U/L) 57.2±1.2 (8-1244) 
  Alkaline phosphatase (U/L) 110.4±1.1 (10-1425) 
  Gamma-glutamyl transpeptidase (U/L) 76.8±2.1 (4.4-3331) 
  Prothrombin time (s) 17.2±4.6 (1.2-80) 
  α-fetoprotein(ng/mL) 1324.6±1677.3 (0.19-287000) 
  Absolute neutrophil count(×109/L) 4.2±5.5 (0.5-58.8) 
  Absolute lymphocyte count(×109/L) 4.2±0.8 (-10.4) 
Child-Pugh 
   A 112 (29.6%) 
  B 205 (54.1%) 
  C 62 (16.4%) 
Child-Pugh score 7.6±1.7(5-13) 
MELD score 6.5±0.7 (5.06-11.9) 
NLR score 6.9±9.3 (0.3-101.4) 
CAGIB score -5.6±1.1 (-7.8-1.6) 
In-hospital death 25 (6.6%) 
MELD, model for end-stage liver disease; NLR, neutrophil to lymphocyte ratio; CAGIB, cirrhosis acute 
gastrointestinal bleeding 
Table 2. Predictors for overall survival in 379 patients with liver cirrhosis and GIB. 
Variable 
Univariate analysis   Multivariate analysis 
OR 95% CI P   OR 95% CI P 
Age 1.043 1.010-1.078 0.011 
 
1.066 1.017-1.118 0.008 
Gender (male/female) 1.041 0.455-2.381 0.925 
    
Etiology (Hepatitis/other) 0.378 0.165-0.865 0.021 
    
AFP  1 1.000-1.000 0.898 
    
HCC (yes/no) 5.417 2.355-12.458 <0.001 
 
7.19 2.077-24.893 0.001 
Diabetes (yes/no) 0.846 0.191-3.748 0.826 
    
History of GIB (yes/no) 1.354 0.546-3.357 0.513 
    
White blood cell  1.166 1.079-1.259 <0.001  
1.123 1.051-1.201 0.001 
Platelet  1.002 0.996-1.008 0.502 
    
Red blood cell 0.26 0.125-0.541 <0.001 
 
0.375 1.131-1.068 0.066 
Hemoglobin  0.987 0.968-1.006 0.175     
Albumin  0.902 0.837-0.972 0.007 
 
1.164 1.031-0.913 0.623 
Total Serum bilirubin  1.013 1.005-1.020 0.001  
1.014 1.005-1.023 0.003 
Serum creatinine 1.017 1.007-1.026 <0.001 
 
1.012 1.004-1.021 0.006 
International normalized ratio 1.009 0.962-1.059 0.712     
Alanine aminotransferase  1.008 1.003-1.012 0.001 
 
1.005 1.000-1.009 0.036 
Aspartate aminotransferase  1.004 1.002-1.006 <0.001     
Alkaline phosphatase  1.002 1.000-1.004 0.036 
 
0.794 0.995-1.006 0.794 
Gamma-glutamyl transpeptidase 1 0.999-1.002 0.524 
    
Child-Pugh score 2.219 1.695-2.905 <0.001 
    
MELD score 2.789 1.743-4.462 <0.001 
    
NLR score 1.046 1.017-1.075 0.002 
    
CAGIB score 3.408 2.214-5.244 <0.001     
HCC, hepatocellular carcinoma; OR, odds ratio; CI, confidence interval; AFP, α-fetoprotein; GIB, Acute 
gastrointestinal bleeding; ALT, alanine aminotransferase; AST, aspartate aminotransferase. 
Child-Pugh score, MELD score, and NLR score are complex variables composed of many clinically 
significant variables, and therefore they were not included in the multivariate analysis. ALT and AST had a 
potential collinearity for assessing liver function and therefore AST were excluded in the multivariate 
analysis. 
 
 
